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Biochemical and immunological sludies have established thai one of lhe signal transducers ol’atrial nalriurclic I’uctor(ANF) is a I80 kDa membrane 
guanylate cyclase (180 kDa mCiC), which is also an ANF rcccptoK obligatory in the transduction process is an intervening AT&regulated step, 
bul ils mechanism is not known. GCa is a newly discovered member of lhc guanylaic cyclasu family whose activiiy is indcpcndenl of the known 
natriuretic peptides, and the enzyme is not an ANF receptor. The genetically tailored GCa. GCrr-DmutGIn~~“Leu”bJ. however, is not only a 
guanylatc cyclase but also an ANF rcwcptor and is slruclurally and functionally idcnlical to the cloned wild-type ANF reccpior guanylate cyclasc. 
GC-A. We now rcporl tha\ the ANF-dependeni guanylaic cyclase aclivhy in Ihe parliculatc fractions of cells transfccted will1 GCa- 
DmutGlnJJ”LeuJM was inhibiled by the 180 kDa mGC polyclonal antibody. and with [his anlibody probe ii was possible to purify the 130 kDa 
expressed receptor; the hormone-dependent cyclase aclivity of this recepior was exclusively dependent upon ATP; and through site-directed 
mutational studies with GCa mulanls, the signaling sequence llial defines ATP binding sile was idenlificd. We thus conclude thai I80 kDa mGC 
and the mulanl protein are immunologically similar; bolh proteins are linked to ihc ANF signal in the generation of cyclic GMP synthesis; and 
in bolh lhc ligand binding and calalylic aclivities are bridged through a defined ATP binding module, 
Alrial natriurelic faclor; Guanylatc cyclase; Cyclic GMP; ATP-binding prolein; Alrial nalriurctic factor recepior guunylatr cyclase 
I. INTRODUCTION 
Atria1 natriuretic factor (ANF) is one of the family 
of structurally related natriuretic peptides that regulate 
hemodynamics of the physiological processes of 
diuresis, water balance, and blood pressure [l-3]. Other 
known members of this family are brain natriuretic pep- 
tide (BNP; [4]) and cardiac natriuretic peptide (CNP; 
[5-71) which, like ANF, stimulate membrane guanylate 
cyclase activity [8]. It is, therefore, possible that the 
second messenger of certain biological responses of 
ANF and other natriuretic peptides is cyclic GMP. 
Consistent with this notion, original biochemical studies 
identifed an unusual bifunctional characteristic of gua- 
nylate cyclase: it is both an ANF receptor and a cyclase 
[g-12]. Two such monomeric proteins, one 120-140 
kDa [9,11,12] and the other 180 kDa (termed 180 kDa 
mGC) [IO], were described. From these findings a new 
concept of transmembrane signaling evolved, which was 
drastically different from the one (at the time) well- 
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established for the adenylatc cyclase system: in 
hormone-dependent adenylate cyclase, there is an as- 
semblage of individual components - receptor, GTP- 
binding protein and catalytic moiety - for signal 
transduction. In contrast, the presence of dual activities 
- receptor binding and enzymic - on a single peptide 
chain indicated that this transmembrane protein con- 
tained both the information for signal recognition and 
its transduction into a second messenger [IO]. This 
mechanism of transmcmbrane signaling involving 
mediation by second messenger, cyclic GMP, is now 
validated and extended by molecular cloning studies; 
the existence of two natriuretic peptide receptors - GC- 
A and GC-B (both of which are also guanylate cyclases) 
- has been documented [13-l 51; GC-A appears to be 3 
receptor for ANF [I 31, GC-B for CNP [ lli], and the 
receptor for BNP is unknown. Thus the existence of a 
natriuretic peptide receptor guanylate cyclase family 
has been established. The family members how a strik- 
ing similarity in their structures, and the predicted to- 
pographical model indicates that all family members 
contain a single membrane-spanning helical domain 
which divides the protein in roughly two equal portions, 
N-terminal extracellular and the C-terminal intracel- 
lular. The receptor domain lies in the extracellular por- 
tion and the intracellular portion contains two domains: 
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the one adjacent to the transmembrane is termed a 
kinase-like domain due to its sequence similarity to the 
tyrosine kinasc family, and the C-terminal region con- 
tains the catalytic domain [13]. Receptor site LeuJG4 in 
GC-A is critical for ANF binding [18]. Recent direct 
biochemical-immunological studies with rat adrenal 
gland and testes complement he molecular cloning 
studies in establishing the multimember nature of ANF 
receptor guanylate cyclase family: both rat adrenal 
gland and testes in addition to the well-characterized 
180 kDa mGC contain an additional 130 kDa ANF 
receptor guanylate cyclase which is immunologically 
identical to the 180 kDa mGC, but the two cyclases are 
separable by GTP-affinity chromatography [17]; most 
probably this 130 kDa ANF receptor guanylate cyclase 
is the counterpart of the originally purified bovine 
adrenal ANF receptor cyclase [11,12]. 
Heterogeneity of natriuretic peptides and their re- 
ceptors indicates that the natriuretic pcptides signaling 
network is complex; each member of the guanylate 
cyclase family may uniquely sense and transduce ach 
natriuretic peptide biological signal. To determine the 
precise mechanism of the whole signaling network, it is 
important o resolve the structural and functional rela- 
tionship between the individual guanylate cyclasc re- 
ceptors identified on a biochemical and molecular clon- 
ing basis. The present study addresses this issue in de- 
termining the biochemical and functional relationship 
between the two atrial natriuretic factor receptor gua- 
nylate cyclases - 180 kDa mGC characterized on a 
biochemical basis, and the genetically tailored ANF re- 
ceptor guanylate cyclase (GCa-DmutGln33*Leu3ti) [ 151, 
which is structurally and functionally identical to the 
cloned GC-A [l3]. The results indicate that the two 
guanylate cyclases are immunologically similar and 
transduce the ANF signal in an identical fashion; ATP 
plays an obligatory role in signaling [19,20]. Immu- 
nological similarity between the two cyclases made it 
possible to use the 180 kDa mGC antibody probe to 
completely purify the genetically tailored enzyme from 
the transfected cells and show its linkage to the ANF- 
dependent cyclasc activity. 
2. MATERIALS AND METHQDS 
ANF (rat 8-33) used in thcsc studies was n %-amino acid pptide 
H-Ar~_Arg-Ser-Scr-Cys-P1~c-Gly-Gly-Ar~IIc-Asp-Ars_lle-Gly-Ala- 
Gin-Ser-Gly-Lcu-Gl~Cys-Asn-Scr.Phe-Ar~Tyr-OH, purchased 
from Peninsula Laboratories; GTP, 3-[(3-cholaimidopropyl)dime~hyl 
ammoniol-l-propane sulfonatc (CHAPS), cyclic GMP, ATP and 
bovine serum albumin were from Sigma; ATPyS and AMP-PNP were 
from Bochringer-Mannhcim. [aJ?P]ATP, and [“51]Nal from 
Amersham. 
GCa-DmutGln31DLru’b was constructed as in [IS]. To build GCa. 
DmuNalSOsAsnJW conversions of Gly505 
dn 
to Vnl, and Ser’” 10 Asn, 
were performe  1.9 kb SUM-XhI fragment of GCacDNA sub- 
cloned into pSelect-I mutagenic vector using primers: sclcction- 
ampicillin-repair (Promega Biotcc Mutagenesis Kit) and mutagenic 
Y-GGAGCCATAAITGTTAACTCGCCCACTCAG-3’. EcoRY- 
Fig. I. Graphical representation of GCa mutants. The thcorclical 
topographical domains of GCu are abbrcviatcd as in [18]: EX-D, 
cxlracellular domain; KL-D, kinasc-like domain; GC-D. guanylatc 
cyclasc domain. The closed box represents lhc lcadcr sequence; the 
sbadcd box, the lransmembranc domain; muiatcd amino acid rcsidnes 
and reslriction she crealcd by muiagcnesis arc bold4ctwrcd. Con- 
slruction of GCa mutants is dcscribcd in Malerials and Melhods. 
Xbal fragment of GCaDmui cDNA in pBluescrip1 vector was rc- 
placed with EcoRV-Xhol frafimeni excised from aSclcct-cDNA rc- 
combinant. Mulation and Ii&on were verified bi double-stranded 
scqucncing (Scqucnasc 2.0, U.S.B.). GCaDmulGln”“Lcu’~K-Cyc- 
w~ls represented bythe 1.65 kb WI-Hpul fragment cxiscd from GCQ- 
DmutVa1505AsnW (Fig. I) For expression stud&., mutants wcrc sub- 
cloned inlo X/WI-8rtnl sites of pSVL expression vector. COS-2A and 
COS.7 cells (simian virus 40-transfonnsd African green monkey 
kidney cells) were transfectcd with the expression vccior by calcium 
phosphate chnique 1281; for cxprcssion of GCa-DmutGIn’%euWK-. 
Cyr, codon TGA from pSVL vccior sequence localL 27 nuclcotidcs 
from lhc 3’ end of the mutant cDNA served as a STOP codon. 
Membranes wcrc prcparcd as in [IS]. and gunnylale cyclasc aclivily 
was debxmined as in [14]. 
GCo-Dmut was purified by immunoaffinily chromatography in
which the affmity ligand was rabbi1 anti-180 kDa mGC polyclonal 
antibody raised against rat adrenocortical carcinoma 180 kDa mGC. 
The purificalion protocol was idcnlical o the one previously dcxribcd 
for the purilicalion of I80 kDa mGC [21], except [hat the GTPmaffinhy 
purification step was omiued; consequently the solubilizcd 
membranes were direcily subjcctcd to the immunoaffinity purification 
step. Eluled fractions were immediately neutralized with 0.1 M Tris. 
pH 8.S. and subjected to SDS-PAGE. 
3. RESULTS AND DISCUSSION 
In this study, the combined tools of biochemistry, 
immunology and recombinant DNA have been utilized 
to determine the structural and functional relationships 
of two ANF receptor guanylate cyclases, the biochcmi- 
tally characterized 180 kDa mGC [lo] and the cloned 
GC-A [13], and to identify the ATP-binding structural 
motif of guanylate cyclase that participates in ANF 
signaling. A plasma membrane guanylate cyclase, GCa, 
which is not an ANF receptor guanylate cyclase, was 
genetically tailored to construct GCa- 
DmutGln33xLeu364 involving two amino acid residue 
substitutions: His33* to Gin and Pro3u to Leu [18]. This 
GCa-Dmut is structurally and functionally identical to 
the cioned wild-type G&A ji3], and was used as a 
prototype of GC-A in the present studies. To determine 
the immunological similarity between GCa- 
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Fig. 2. Stimulstion or particulate guanylatc cyclase ectivity by ANF 
and its inhibition by 180 kDa mcmbranc guanylate cyclasc polyclonal 
antibody. COS-?A ccl1 membranes transfectcd with GC-A were pre- 
incubated with or without antibody (I@ fraction) for I h on ice, 
followed by assay Tar guanylatc cyclase activity in the absence or 
presence of ANF (IO-’ M). Prc-immune serum was used for control. 
The experiments wcrc done in triplicate and repeated two times, al- 
though the data depicted is from one typical experiment. The mean 
t SEM is shown. Memb.. COS-?A cell membranes LransTccted with 
GGA; NRS, normal rabbit serum; Al3. I80 IiDa mGC antibody. 
DmutGln33”Leu3G’ and lS@ kDa mGC. the 180 kDa 
mGC polyclonal antibody probe was used. This probe 
is highly specific to the structural determinants of 180 
kDa mGC, including the ANF-dependent cyclase 
cpitope (see [21] for details of the antibody specificity). 
The coding sequence of GCa-DmutGln338Leu3G4 was 
introduced into an expression vector, pSVL, under the 
transcriptional control of the SV4O late promoter, 
which was then used to transfect COS cells. The particu- 
late fractions of these cells were appropriately treated 
and analyzed for cyclase activity, and where indicated 
for the ATP binding activity. 
ANF stimulated by approximately 3-fold the particu- 
late guanylate cyclase activity of the expressed protein, 
and nearly 70% of the stimulated activity was blocked 
by the 1 SO kDa mGC polyclonal anti body (Fig. 2); non- 
immune rabbit serum had no influence on the stimu- 
lated activity. Thus the 180 kDa mGC and the mutant 
protein are immunologically similar, and both proteins 
are linked to the ANF-dependent cyclic GMP synthesis. 
Less than complete blockage of the hormone-dependent 
cyclsse activity of the recombinant protein suggests 
minor structural differences between this and the 180 
kDa protein. 
The shared feature of immunological identity be- 
tween 180 kDa mGC and GCa-DmutGln33sLeu3G4 
proteins formed the basis of purification of the mutant 
receptor guanylate cyclase by the 180 kDa mGC anti- 
body probe. The immonopurified enzyme showed a 
single Coomassie blue-stained 130 kDa protein band, 
although the non-immunopurified fraction showed 
multiple protein-stained bands [Fig. 3A) To determine 
the biochemical uthenticity of the immunopurified I30 
kDa protein as the ANF receptor, the expressed protein 
in plasma membranes was affinity-crosslinked with 
[12SI]ANF through disuccinamide suberate. SDS-PAGE 
under reducing conditions revealed a 130 kDa labeled 
band (Fig. 38, lanes 3 and 4). Because the labeling was 
abolished upon inclusion of the non-radioactive ANF 
(1 /lM) in the reaction mixture (Fig. 3B: compare lane 
3 with 4), the 130 kDa protein represented as true ANF 
receptor. Therefore, we conclude that the immuno- 
purified 130 kDa guanylate cyclase is an authentic ANF 
receptor, is biologically linked to the ANF signal, and 
is immunologically similar to the 180 kDa mGC. 
In previous studies an assignment of the molecular 
weight of 130 kDa to the GC-A-expressed protein was 
based solely on the [‘“SI]ANF crosslinking studies 
[15,20]; the protein was not purified and thus no gua- 
nylate cyclase activity could be demonstrated toco-exist 
in the 130 kDa protein. With the availability of the 
cyclase antibody probe, the present results establish that 
the cloned 130 kDa expressed protein is indeed both a 
guanylate cyclase and an ANF receptor, as is the case 
with the 180 kDa mGC. It is anticipated that this anti- 
body probe will now prove invaluable in direct charac- 
terization, quantifying and purifying GC-A in cells of 
diverse nature, the task so far hampered ue to the 
extremely low occurrence of these receptors in cellular 
plasma membranes. 
Previous studies have shown that depending upon the 
A) 61 
MrX10-3 MrXlO” 
1 2 6 4 6 6 
Fig. 3. (A) 5DS&75% polyacrylamide gel electrophcxsis (SDS- 
PAGE) analysis of immunoalIinity purified 130 kDa membrane gua- 
nylate cyclasc from CCXXA cell membranes transfected with GC-A 
(lane I); (lane 3) solubilizcd membranes. I ~(g oT:he immunoaffinity 
puriged fraction was subjected to 8.75% SDS-PAGE and visualized 
with Coomassic blue. (B) GCa mutants crosshnking with [rz51]ANF. 
Membranes oTCOS-2A cells trausfccted with GCa-DmutGln’ULeu’” 
(lanes 3 and 4) and GCa-DmutGlnJ’“Leu”“KCyc- (loncs 5 and 6) 
were incnbated in a total volume or 100 yl with [1251]ANF without 
(lanes 3 and S) or with (lanes 4 and 6) 1 ,L~M ANF at room temperature 
for 2 h, followed by incubation with disuccinamide suberate (DSS) ror 
I5 min on ice. Mcmbroncs were subjected to 7.5% SDS-PAGE, and 
the gel was autoradiographcd for 7 days at -7O’C. 
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Fig. 4. Effect of ATP and its analogs on basal and ANF-dcpcndent 
membrane guanylate cyclase activities in the presence of RI&‘+ as 
cofactor. COS-2A cell membranes transfected with GC-A were as- 
sayed for guanylate cyclase activity in the absence or presence of ANF 
(IO-’ M) and increasing concentrations of ATP, ATPyS and AMP- 
PNP. The experiment was done in triplicnte and repeated three times. 
although the datu depicted is from one typical experiment. The mean 
+ SEM is shown. 
cofactors Mg’” or MI?‘, ATP enhances [ 19,20,22] or 
diminishes the ANF-dependent cyclase activity [19]. 
The ATP-stimulatory effect was assessed on the geneti- 
cally tailored guanylate cyclase signaling. The 
membranes of GCa-DmutGln”3”Leu3~-transfected cells 
were incubated with a series of increasing concentra- 
tions of ATP or its non-hydrolyzable analogs with or 
without ANF. With Mg?’ as cofactor, ATP and its 
analogs - ATDyS and AMP-DNP - alone did not alter 
the basal cyclase activity, and ANF by itself caused only 
a modest (ml .S-2-fold) cyclase stimulation(Fig. 4). These 
studies are in genera! agreement with previous studies, 
showing that ATP and ANF by themselves do not 
stimulate the cyclase activity 119,201, although the pres- 
ent study demonstrates that ANF by itself has a small 
stimulatory cyclnse ffect. 
In the presence of saturating amounts of ANF (lo-’ 
M), ATP, and its analogs, stimulated the cyclase activity 
in a dose-dependent fashion (Fig. 4); the order of max- 
imal cyclase activation and potency was ATPyS > ATP 
> AMP-PNP - their respective ECSo values being 0.16, 
0.25 and 0.38 mM. 
Thus these ATP results showed an almost exclusive 
requirement of ATP in AN-F signaling, and are in gen- 
eral agreement with those obtained with the crude testi- 
cular plasma membranes containing 180 kDa mGC [ 191 
and those expressing GC-A [20]. 
To account for the ATP stimulatory effect, two mech- 
anisms have been proposed - direct and indirect. Both 
mechanisms predict hat the guanylate cyclase molecule 
contains a structural module which is allosterically 
regulated by ATP, and this putative ATP-regulatory 
module bridges the binding-signal with the signal 
transduction. In the indirect mechanism [22,24], interac- 
tion between ATP and the putative ATP-regulatory 
module is through a separate ATP-binding protein, 
whereas in the direct mechanism the regulatory module 
is the direct ATP binding site 1251. The direct mccha- 
nism is supported by two observations: (i) the ho- 
mogeneous lS0 kDa mGC specifically binds ATP [19]; 
(ii) the GC-A mutant lacking a kinase-like domain is 
not stimulated by ATP [25], indicating that the ATP 
binding site resides in the kinase-like domain of the 
guanylate cyclase. However, the identity of ATP regu- 
latory module is missing. 
To address the missing-identity issue, direct ATP- 
binding studies were conducted with GCa- 
DmutG!n338Leu3~ and two of its secondary mutants, 
one in which the entire kinase-like and cyclase domains 
are deleted (GCa-DmutG!n33nLeuWK-Cyc-) and the 
other (GCa-DmutVa1505Asn50 in which the glycine-rich 
cluster (Grc)-sequence is disrupted by a sequence 
change from Gly 503-X-Gly-X-X-X-Gly5~ to Glyso3-X- 
X-X-X-X-GlySm (Table I). This sequence was chosen 
because it is the modified form of the nuclcotidc-binding 
consensus sequence of protein kinases [26,27], although 
no protein kinase activity has been demonstrated in 
guanylate cyclase. There was no significant difference in 
the ATP-binding specific activity between the 
membranes of GCa-DmutGln33nLeu3%K-Cyc- mutant 
and the membranes of control cells transfected with 
pSVL alone (Table 1). The expressed GCa- 
DmutGln’““Leu”6’KCyc- mutant contained the ANF 
binding activity as was shown by [‘“51]ANF crosslinking 
(Fig. 3B, lanes 5 and G); the M, of the radioactive band, 
-70 kDa, agrees wit!1 the calculated value of the receptor 
portion that is in the glycosylated state. In contrast 
there was almost 3.5.fold higher ATP-binding specific 
activity in the GCa-DmutG!n338Leu3b membranes over 
the control membranes, indicating that the ATP binding 
site is located somewhere in the intracellular domain of 
guanylate cyclase. When the ATP-binding results were 
compared between the membranes expressing GCa- 
DmutGln33”Leu3G” and those expressing the disrupted 
&c-sequence (GCa-DmutValSo5AsnS), the disrupted 
Grc-sequence mutant showed only marginal ATP-bind- 
ing activity. These results establish that the Grc-se- 
qwnce Gly503-X-Gly-X-X-X-G!ys~ is the ATP binding 
site of guanylate cyclase. Our ongoing studies (manu- 
script in preparation) using a variety of GCa mutants 
show that this &c-sequence motif also is pivotal in 
ANF-dependent cyclase activation. It is, therefore, con- 
cluded tllat this structural motif represents the module 
of guanylate cyclase where ATP binds and potentiates 
the ANF-binding signal, which then is transduced at the 
catalytic site of the guanylate cyclase. 
These results supporting the direct mechanism of 
ATP action in ANF signaling raise an important ques- 
tion: is this signal transduction mechanism shared by all 
members of the natriuretic peptide receptor guanylate 
cyclase family? The question cannot be answered at this 
time. There are three known natriuretic I>eptides, ANF, 
BNP and CNP. Receptors for only two, ANF and 
CNF, have been identified, and to date the only ATP 
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Membranes of COS-7 cells were incu>dlcd in a lolal volume of 100 
yl with [y.‘?P]ATP (- IOD cpntitube; specilic activity 4,500 Cilmmol) in 
the presence of 4 mM Mg?*. at room temperature for 5 min. 
Membranes were filtered through GF/C filters and washed 4-times 
with ice-cold phosphate buffered saline, pH 7.5. Non-specific binding 
was measured in the presence of IO-” M ATP. Specilic binding was 
calculated by subtracting the non-specific radioactivity from the total 
radioactivity bound lo the filters. Values arc avrrapc of duplicate 
determinations from ;1 representative experiment. 
study conducted with a homogeneous receptor is that 
of ANF [SO]. Studies with the crude rat lung membranes 
and liver indicate that ATP and its nonhydrolyzable 
analogs by themselves activate basal particulate gua- 
nylate cyclase [Z-24]. Because the activation is lost 
upon partial purification of the enzyme, however, it is 
possible that in certain signaling processes the indirect 
mechanism operates, as predicted [23,24]. 
In conclusion, this study demonstrates immunologi- 
cal identity between two ANF receptor guanylate 
cyclases, one characterized on a biochemical basis and 
the other on the basis of molecular cloning. Availability 
of the antibody probe for the first time has established 
the direct coupling of ANF signal with the molecularly 
cloned receptor and, in this study, has made it possible 
to purify this receptor from the crude tissues. In addi- 
tion, the antibody probe has identified the sequence of 
the ATP-binding site of guanylate cyclase that may be 
important in bridging the ANF-binding signal with 
signal transduction, the events occurring at the extracel- 
Mar receptor site and at the intracellular catalytic site 
of guanylate cyclase. 
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